Ex-Louisiana politicians call for Rx aid for US citizens
The Pharmaceutical Research and Manufacturers of America (PhRMA) has renewed its campaign to raise public awareness of the Partnership for Prescription Assistance program to provide help to US citizens who are unable to afford innovative medicines.
Billy Tauzin, the group's president and chief executive, said: "for four years the PPA has been a trusted resource for nearly six million Americans." Mr Tauzin, who was a member of the House of Representatives for the poorest US state, Louisiana, noted that some patients would be able to obtain medicines free of charge.
The call coincided with Medicare Today's spokesman, Jim Breaux, a former Democrat Senator from Louisiana, who urged low-income seniors to register for the Medicare Part D prescription drug benefit, following a survey that indicates that four in 10 eligible people are unaware of the scheme (Marketletter May 11).
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze